Fuller & Thaler Asset Management’s Medifast MED Stock Holding History

Fuller & Thaler Asset Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-140	Closed	-$15K	–	502
2019 Q4	$15K	Hold	140	–	–	﹤0.01%	451
2019 Q3	$15K	Hold	140	–	–	﹤0.01%	454
2019 Q2	$18K	Hold	140	–	–	﹤0.01%	432
2019 Q1	$18K	Hold	140	–	–	﹤0.01%	417
2018 Q4	$18K	Hold	140	–	–	﹤0.01%	415
2018 Q3	$31K	Sell	140 -105	-43%	-$21.3K	﹤0.01%	379
2018 Q2	$39K	Hold	245	–	–	﹤0.01%	700
2018 Q1	$23K	Buy	+245	New	+$18.3K	﹤0.01%	713
2016 Q1	–	Sell	-1,900	Closed	-$58K	–	834
2015 Q4	$58K	Buy	+1,900	New	+$56.6K	﹤0.01%	588

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Fuller & Thaler Asset Management's MED Position: Q1 2020 in Review

Fuller & Thaler Asset Management sold out of Medifast (MED) in Q1 2020, closing a stake of 140 shares — an estimated $15K sold.

Fuller & Thaler Asset Management first reported a position in MED in Q4 2015 and held it in 9 quarters. The position peaked at $58K in Q4 2015. 201 funds tracked by Wall St. Rank hold MED as of Q1 2020.

Fuller & Thaler Asset Management reported no remaining Medifast position as of Q1 2020 after selling out during the quarter.
Fuller & Thaler Asset Management sold 140 Medifast shares in Q1 2020, an estimated $15K.
Fuller & Thaler Asset Management first reported a position in Medifast in Q4 2015 and held it in 9 quarters.
Fuller & Thaler Asset Management's Medifast position peaked at $58K in Q4 2015.
201 funds tracked by Wall St. Rank held Medifast as of Q1 2020.

Based on Fuller & Thaler Asset Management's 13F filing for Q1 2020, filed 6 May 2020.